Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients

Journal of the American College of Cardiology

Volumn 31, Issue 2, 1998, Pages 252-258

  Seggewiss, Hubert ^a   Gleichmann, Ulrich ^a   Faber, Lothar ^a   Fassbender, Dieter ^a   Schmidt, Henning K ^a   Strick, Stefan ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BALLOON CATHETER; CATHETER ABLATION; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; HEART MUSCLE; HEART RHYTHM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MUSCLE RESECTION; PRIORITY JOURNAL; TECHNIQUE; TREATMENT OUTCOME;

EID: 0031976561     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00508-1     Document Type: Article

References (38)

1. Marian AJ, Mares A Jr, Kelly DP, et al. Sudden cardiac death in hypertrophic cardiomyopathy. Eur Heart J. 16:1995;368-376.
2. Schwartz K. Familial hypertrophic cardiomyopathy nonsense versus missense mutations . Circulation. 91:1995;2865-2867.
3. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy clinical spectrum and treatment . Circulation. 92:1995;1680-1692.
4. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med. 334:1996;1039-1044.
5. Frank MJ, Abdulla AM, Canedo MI, Saylors RE. Long-term medical management of hypertrophic obstructive cardiomyopathy. Am J Cardiol. 42:1978;993-1001.
6. Haberer T, Hess OM, Jenni R, Krayenbühl HP. Hypertrophic obstructive cardiomyopathy spontaneous course in comparison to long-term therapy with propanolol and verapamil . Z Kardiol. 72:1983;487-493.
7. Harrison DC, Braunwald E, Glick G, Mason DT, Chidsey CA, Ross J Jr. Effects of beta-adrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis. Circulation. 29:1964;84-98.
8. Kaltenbach M, Hopf R, Kober G, Bussmann WD, Keller M, Petersen Y. Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br Heart J. 42:1979;35-42.
9. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy . Circulation. 90:1994;2731-2742.
10. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet. 339:1992;1318-1323.
11. Kappenberger L. Pacing for obstructive hypertrophic cardiomyopathy. Br Heart J. 73:1995;107.
12. Bircks W, Schulte HD. Surgical treatment of hypertrophic obstructive cardiomyopathy with special reference to complications and to atypical hypertrophic obstructive cardiomyopathy. Eur Heart J. 4:(Suppl F):1983;187-190.
13. Kirklin JW, Ellis FR Jr. Surgical relief of diffuse subvalvular aortic stenosis. Circulation. 24:1961;739-742.
14. Kuhn H, Gietzen F, Mercier J, et al. Untersuchungen zur Klinik, zum Verlauf und zur Prognose verschiedener Formen der hypertrophischen Kardiomyopathie. Z Kardiol. 72:1983;83-98.
15. Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis technique and hemodynamic results of subaortic ventriculotomy . Ann Surg. 154:1961;181-189.
16. Schulte HD, Bircks W, Lösse B. Techniques and complications of transaortic subvalvular myectomy in patients with hypertrophic obstructive cardiomyopathy (HOCM). Z Kardiol. 76:(Suppl 3):1987;145-151.
17. McCully RB, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation. 94:1996;467-471.
18. Robbins RC, Stinson EB, Daily PO. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 111:1996;586-594.
19. Heric B, Lytle BW, Miller DP, et al. Surgical management of hypertrophic obstructive cardiomyopathy Early and late results . J Thorac Cardiovasc Surg. 110:1995;195-208.
20. Schoendube FA, Klues HG, Reith S, Flachskampf Hanrath P, Messmer BJ. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation. 92:(Suppl II):1995;II-122-II-127.
21. Kuhn H, Gietzen F, Leuner C, Gerenkamp T. Induction of subaortic ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Eur Heart J. 18:1997;846-851.
22. Sigwart U. Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy. Lancet. 346:1995;211-214.
23. Gietzen F, Leuner C, Gerenkamp T, Kuhn H. Katheterinterventionelle Therapie der hypertrophisch obstruktiven Kardiomyopathie durch Alkoholablation des ersten Septalastes der linken Koronararterie [abstract]. Z Kardiol. 85:(Suppl 2):1996;3.
24. Faber L, Seggewiß H, Faßbender D, Bogunovic N, Gleichmann U. Acute echo- and electrocardiographic changes after interventional myocardial ablation in obstructive hypertrophic cardiomyopathy [abstract]. Eur Heart J. 17:(Suppl):1996;48.
25. Gleichmann U, Seggewiß H, Faber L, Faßbender D, Schmidt HK, Strick S. Kathetertherapie der hypertrophen obstruktiven Kardiomyopathie. Dtsch Med Wochenschr. 21:1996;679-685.
26. Seggewiß H, Gleichmann U, Faber L, Faßbender D, Schmidt HK, Strick S. Hämodynamische und klinische Akutergebnisse der Kathetertherapie bei hypertropher obstruktiver Kardiomyopathie [abstract]. Z Kardiol. 85:(Suppl 5):1996;460.
27. Teare RD. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 20:1958;1-8.
28. Spirito P, Rapezzi C, Autore C, et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation. 90:1994;2743-2747.
29. Vassalli S, Seiler G, Hess OM. Risk stratification in hypertrophic cardiomyopathy. Curr Opin Cardiol. 9:1994;330-336.
30. Chang AC, McAreavey D, Fananapazir L. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death. Curr Opin Cardiol. 10:1995;9-15.
31. Maron BJ, Roberts WC, Edwards JE, McAllister HA, Foley DD, Epstein SE. Sudden death in patients with hypertrophic cardiomyopathy characterization of 26 patients without functional limitations . Am J Cardiol. 41:1978;803-810.
32. Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE. Sudden death in young athletes. Circulation. 62:1980;218-229.
33. Romeo F, Pellicia F, Christofani R, Martuscelli E, Reale A. Hypertrophic cardiomyopathy is the left ventricular outflow gradient a major prognostic determinant? Eur Heart J. 11:1990;233-240.
34. Nishimura RA, Hayes DL, Ilstrup DM, Holmes DR Jr, Tajik AJ. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy acute Doppler echocardiographic and catheterization hemodynamic study . J Am Coll Cardiol. 27:1996;421-430.
35. Maron BJ. Appraisal of dual-chamber pacing therapy in hypertrophic cardiomyopathy too soon for a rush to judgment? J Am Coll Cardiol. 27:1996;431-432.
36. Brugada P, de Swart H, Smeets JLRM, Wellens HJJ. Transcoronary chemical ablation of ventricular tachycardia. Circulation. 79:1989;475-482.
37. Faber L, Seggewiß H, Faßbender D, Strick S, Bogunovic N, Gleichmann U. Identification of the target vessel (TV) in percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy by myocardial contrast echocardiography (MCE) [abstract]. Circulation. 96:(Suppl I):1997;I-639.
38. Knight C, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy outcome in the first series of patients . Circulation. 95:1997;2075-2081.